RT @ericdeinmd: #ACR21 L16 - Breakthrough #COVID19 in rheum pts âï¸Breakthrough ifn ~4%, compared to 3% wo rheum dise
Tweet Content
#ACR21 L16 - Breakthrough #COVID19 in rheum pts
⭐️Breakthrough ifn ~4%, compared to 3% wo rheum disease. Statistically signif ⬆️ risk in RA, gout, polymyositis, vasculitis, multiple rheum disease
⭐️bDMARD, multiple AIRD risks
@Rheumnow https://t.co/cuM9LcEr4u https://t.co/Los2n7BoIn
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off